In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on Inovio Pharmaceuticals (INO – Research
Tag: Jason McCarthy
BioTime (BTX) Gets a Buy Rating from Maxim Group
Maxim Group analyst Jason McCarthy maintained a Buy rating on BioTime (BTX – Research Report) today and set a price
Teva Pharma (TEVA) Gets a Hold Rating from Maxim Group
Maxim Group analyst Jason McCarthy maintained a Hold rating on Teva Pharma (TEVA – Research Report) today. The company’s shares
Veru Inc (VERU) Receives a Buy from Maxim Group
Maxim Group analyst Jason McCarthy maintained a Buy rating on Veru Inc (VERU – Research Report) today and set a
ADMA Biologics (ADMA) Receives a Buy from Maxim Group
In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on ADMA Biologics (ADMA – Research
Maxim Group Thinks Onconova Therapeutics’ Stock is Going to Recover
In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on Onconova Therapeutics (ONTX – Research
Maxim Group Reaffirms Their Buy Rating on BioNano Genomics Inc (BNGO)
Maxim Group analyst Jason McCarthy maintained a Buy rating on BioNano Genomics Inc (BNGO – Research Report) today and set